Skip to main content
Clinical Trials/IRCT20191231045968N1
IRCT20191231045968N1
Completed
Phase 3

Clinical trial of the effect of curcumin supplementation plus resistance training compared with the placebo on disease severity and metabolic profiles in patients with Parkinson's

Kharazmi University0 sites40 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Kharazmi University
Enrollment
40
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with Parkinson's
  • Aged 50 to 80 years

Exclusion Criteria

  • Taking antioxidants supplements
  • Taking anti\-inflammatory supplements
  • Severe psychosis
  • hypo\- and hyperthyroidism
  • Consuming curcumin supplements within 3 month prior to the study
  • Restrictions to practicing exercise, including cardiovascular disease, stroke, respiratory problems and any surgical procedures for the treatment of PD e.g., deep brain stimulation (DBS).
  • Motor deficits that could limit performance in exercise in the study
  • Practicing any regular physical activity except for resistance training in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials